| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 100.52% | Scotiabank | → $23 | Initiates Coverage On | → Sector Outperform |
| 03/16/2023 | 117.96% | JMP Securities | $30 → $25 | Maintains | Outperform |
| 11/11/2022 | 161.55% | JMP Securities | $26 → $30 | Maintains | Market Outperform |
| 07/19/2022 | 126.68% | JMP Securities | → $26 | Initiates Coverage On | → Market Outperform |
| 11/23/2021 | 231.3% | BTIG | → $38 | Initiates Coverage On | → Buy |
| 11/23/2021 | 205.14% | Evercore ISI Group | → $35 | Initiates Coverage On | → Outperform |
| 11/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/23/2021 | 248.74% | SVB Leerink | → $40 | Initiates Coverage On | → Outperform |
What is the target price for Aura Biosciences (AURA)?
The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by Scotiabank on July 27, 2023. The analyst firm set a price target for $23.00 expecting AURA to rise to within 12 months (a possible 100.52% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aura Biosciences (AURA)?
The latest analyst rating for Aura Biosciences (NASDAQ: AURA) was provided by Scotiabank, and Aura Biosciences initiated their sector outperform rating.
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
Is the Analyst Rating Aura Biosciences (AURA) correct?
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a initiated with a price target of $0.00 to $23.00. The current price Aura Biosciences (AURA) is trading at is $11.47, which is within the analyst's predicted range.